ARTICLE | Company News
VaxGen infectious news
April 14, 2008 7:00 AM UTC
VaxGen will restructure for a fourth time and reduce headcount by about 17 (75%) to 5 to minimize expenses following the termination of a proposed merger with Raven Biotechnologies Inc. (South San Fr...